The Tesla Shock Nobody Sees Coming
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
Shares Stats
| Shares Outstanding | 130,310,000 |
| Shares Float | 124,670,000 |
| Shares Short | 3,330,000 |
| Insider Holdings | 380% |
| Institution Holdings | 97.50% |
About Alnylam Pharmaceuticals Inc
Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference. It offers ONPATTRO and AMVUTTRA for hereditary transthyretin-mediated amyloidosis; GIVLAARI for acute hepatic porphyria; OXLUMO for primary hyperoxaluria type 1; and Leqvio for hypercholesterolemia. It also develops vutrisiran, which is in phase III clinical trial for transthyretin amyloidosis (ATTR) with cardiomyopathy; Nucresiran that is in phase I clinical trial for ATTR amyloidosis; Fitusiran, which is in phase III clinical trial for hemophilia; cemdisiran that is in phase III clinical trial for Myasthenia Gravis and paroxysmal nocturnal hemoglobinuria, and geographic atrophy; and ALN-6400, which is in phase I clinical trial for bleeding disorders. In addition, the company is also developing Zilebesiran, which is in phase II clinical trial for hypertension; Rapirosiran that is in phase II clinical trial for Metabolic dysfunction-associated steatohepatitis; ALN-4324, which is in phase I clinical trial for type 2 diabetes mellitus; ALN-PNP that is in phase I clinical trial for non-alcoholic fatty liver disease; ALN-APOC3, which is in phase I clinical trial for dyslipidemia; Mivelsiran that is in phase II clinical trial for cerebral amyloid angiopathy, and phase I clinical trial for Alzheimer's disease; and ALN-HTT02 that is in phase I clinical trial for Huntington's disease. Further, it develops ALN-SOD, which is in phase II clinical trial for SOD1 Amyotrophic lateral sclerosis; Elebsiran that is in phase II clinical trial for Hepatitis B and D virus infections; ALN-BCAT that is in phase I clinical trial for hepatocellular carcinoma; and ALN-ANG3. It has collaborations with Regeneron Pharmaceuticals, Inc.; Roche Holding AG; Regeneron Pharmaceuticals, Inc.; Sanofi S.A.; Novartis AG; PeptiDream, Inc; Dicerna Pharmaceuticals, Inc.; and Ionis Pharmaceuticals, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
General
| Name | Alnylam Pharmaceuticals Inc |
| Ticker | ALNY |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 2,230 |
Highlights
| Analyst Target | 336.59 |
| Market Cap | 41,170,100,000 |
| PEG Ratio | -0.49 |
| EBITDA | -57,815,000 |
Financials
| Curr Year EPS Estimate | 1.03 |
| Next Quarter EPS Estimate | -0.26 |
| Profit Margin | -11.49% |
| Operating Margin | -4.91 |
| Return on Assets | -0.02 |
| Return on Equity | -15.01 |
| Revenue | 2.3B |
| Earnings Per Share | -2.11 |
| Revenue Per Share | 18.27 |
| Gross Profit | 2,019,664,000 |
| Quarterly Revenue Growth | 0.20 |
Valuation
| Forward PE | 2,000 |
| Price/Sales (Trailing 12 Mt.) | 17.49 |
| Price/Book (Most Recent Quarter) | 355.74 |
Earnings
Trump's 'Big, Beautiful Bill' Offers Seniors A $6,000 'Bonus' Tax Deduction: Here's How You Qualify For The Benefit
Trump's Big, Beautiful Bill offers a $6,000 senior bonus deduction from 2025-28. Couples can save $12,000. Retirees with incomes up to $75,000 benefit most.
After Diddy's conviction, here's where his business ventures stand
LOS ANGELES (AP) — Sean “Diddy” Combs has been in his federal sex trafficking trial, but that doesn't mean the once-celebrated music mogul will see his business empire restored.
CPA and CFA Says You Have Way Too Many Stocks - Just Buy These 3 - Ad
After years working at the biggest accounting firms like Deloitte and KPMG, Joel Litman (who's also a member of the Global CFA Institute) figured out a unique, less-risky way to grow rich in the stock market. Litman says you don't need dozens of investments, overpriced advisers, or hedge funds. You just need these 3 stocks, which have helped Litman's own mom earn 3,400%.
Inside The Trump Family's $620 Million Crypto Empire
Since retaking the White House, Donald Trump's reported net worth has remained broadly stable, around $6.5 billion on Election Day to roughly $6.4 billion today.
Lisa Murkowski Defends Alaska Carveouts As Elizabeth Warren, Bernie Sanders And Rand Paul Condemn Trump's 'Big Beautiful' Bill: 'Not Good Enough For The Rest Of Our Nation'
Senators across party lines are fiercely divided over Donald Trump's $3.3 trillion "Big Beautiful Bill," which narrowly passed the Senate and now heads to the House amid concerns over debt, tax cuts, and social program rollbacks.
From Ferrari to Bombardier - This Tiny Company Is Everywhere - Ad
A $150M disruptor is transforming glass into real-time displays and vision systems. Already embedded in global OEMs and Tier 1s, it's scaling fast - yet still under Wall Street's radar.
Musk Third-Party Odds Hit 47% — Can The Tesla Chief Do What No One Has Since 1853?
A promise to create a third party from billionaire Elon Musk comes with historical difficulties of challenging the current two-party system.
Bitcoin, Ethereum, Dogecoin Climb As Trump Labels Growing BTC Adoption As 'Great Thing': Sell Pressure On Largest Crypto May Be Fading Away, Says Analyst
Leading cryptocurrencies rose Sunday as President Donald Trump called Bitcoin’s growing adoption a “great thing” for the United States.
Copper's Spiking - And This Junior Has the Grades to Match - Ad
Copper is climbing again - and this time, it looks tariff-proof. A $31M junior just posted nearly 1B lbs of copper equivalent. With insiders and institutions piling in, this could be the next breakout.
Medicaid, food aid recipients worry about safety net cuts in bill sent to Trump
JEFFERSON CITY, Mo. (AP) — Supporters of the that Congress has sent to President Donald Trump say the changes to Medicaid, food aid and other programs will encourage personal responsibility and halt those scamming the system.
Nike soars on a production shift away from China, but it warns of a $1 billion tariff hit
Nike's shares jumped at the opening bell Friday after the company said it's shifting some production away from China. But it also warned that tariffs imposed by the Trump administration will cost it about $1 billion before it makes internal changes, which include “surgical” price increases in the U.S. starting this fall.
Copper's Rally Is Back. This $31M Junior Is Sitting on a Potential Fortune - Ad
A high-grade copper-gold discovery in Quebec just delivered extremely high grade intercepts. Valuation? Just $31M. With copper breaking out, the timing here could be perfect. Get the symbol here.
Dan Ives Urges Apple 'To Make A Move,' Saying That Perplexity Acquisition Is 'A No-Brainer': 'It's A Matter Of When And Not If'
Tech bull Daniel Ives has urged Tim Cook's Apple to make quick moves and acquire Perplexity AI for its search engine.
Donald Trump Drops Hint About Potential TikTok Buyer, But Keeps Details Close To His Chest
President Trump has indicated the presence of a potential buyer for the US operations of TikTok.
Gold Just Hit Another Record. This Junior Could Be Next. - Ad
This copper junior was the smallest company invited to a top global mining conference. With nearly 1B pounds CuEq and 50,000m of funded drilling, this story won't stay quiet for long.
Trump Brokers Peace Deal Between DR Congo And Rwanda — Now Eyes Billions In US Investment
Trump brokers a peace deal between DR Congo and Rwanda, aiming to end conflict and unlock U.S. investment in critical African minerals.
Diddy Jury Deadlocked On Racketeering Conspiracy Charge As Verdicts Reached On Sex Trafficking Counts — Jurors To Return Wednesday
Jurors in Sean "Diddy" Combs' trial reached verdicts on four charges related to sex trafficking but remain deadlocked on the racketeering conspiracy charge, with deliberations set to continue.
Stunning Trump Policy Unlocks Upfront Cash Payouts - Ad
The U.S. has collected $15B from Trump's tariffs - and now, thanks to Title 15, you could claim your own $100-$1,000 instant upfront cash payouts. No stocks needed. Use your phone and this income technique to collect upfront payouts now.
China's humanoid robots generate more soccer excitement than their human counterparts
BEIJING (AP) — While China's men's soccer team hasn't generated much excitement in recent years, humanoid robot teams have won over fans in Beijing based more on the AI technology involved than any athletic prowess shown.
A Vermont dairy farm was raided. The mixed messages from Washington since then have increased fears
MONTPELIER, Vt. (AP) — After six 12-hour shifts milking cows, José Molina-Aguilar's lone day off was hardly relaxing.
Elon's Greatest Invention... Hidden in South Memphis? - Ad
In South Memphis, I uncovered what could be Elon Musk's biggest invention yet. It's so secretive, rivals are flying drones to spy on it. If you're serious about investing in AI, now's the time to see what's really going on inside those walls.
Iran's Top Diplomat To UN Says Uranium Enrichment To Continue: An 'Inalienable Right'
Iran reaffirms commitment to nuclear program despite US strikes. Ambassador cites Non-Proliferation Treaty as justification. Impact remains debated.
Nike Beats The Street And Says The Worst Is Over
Nike Inc (NKE) stock rallies after upbeat fiscal Q4 results. Analysts maintain Buy ratings, raise price targets, citing potential for growth.
$1,016/Day in Crypto - Witness the Proven Strategy Now - Ad
Last chance! The "365x Return in 90 Days" crypto Workshop replay disappears this [DAY]. Discover the simple, 92%-win-rate system that turned $250 into $91,457-no charts, no stress.
This Isn't Your Father's BlackBerry, And Its Comeback Is Gaining Traction
BlackBerry (NYSE: BB) shares rise on better-than-expected Q1 results and raised fiscal guidance. Analysts increase price forecasts.
Carnival's Wild New Private Resort Makes Waves With Huge Swim-Up Bar, Giant Sandcastle
Celebration Key features a mile-long beach, the world's largest swim-up bar, a 10-story sandcastle featuring two water slides and a massive man-made lagoon.
Unveil the 365X Crypto Secret - Replay Disappearing Soon! - Ad
Only 12 hours left! Watch the replay of the "365x Return in 90 Days" crypto Workshop before it's gone. Discover Joel and Adam's 4-part system, real success stories, and how to start mirroring their trades. This is your last chance-don't miss out.
Senate GOP removes tax on solar and wind energy but dismantles climate law passed by Democrats
WASHINGTON (AP) — The approved by the Senate Tuesday removes a proposed tax on solar and wind energy projects but quickly phases out tax credits for wind, solar and other renewable energy.
Trump says he’s terminating trade talks with Canada over tax on technology firms
WASHINGTON (AP) — President Donald Trump said he’s immediately suspending over its plans to continue with its tax on technology firms, which he called “a direct and blatant attack on our country.”
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
Boeing Rises 2.8% After Key Trading Signal
A significant trading signal occurred for Boeing stock, as it demonstrated a power inflow at $209.02, after which BA rose up to 2.8%.
ProKidney Stock Shoots Up Over 8% After Hours After Staggering 515% Rally On Wednesday
ProKidney (NASDAQ: PROK) experienced a surge of 515% during Tuesday's trading session and gained additional 8.58% after-hours to $4.05 on positive Phase 2 trial results, with trading volume seeing a jump to 39.8 million shares from an average of 1.12 million.
CPA and CFA Says You Have Way Too Many Stocks - Just Buy These 3 - Ad
After years working at the biggest accounting firms like Deloitte and KPMG, Joel Litman (who's also a member of the Global CFA Institute) figured out a unique, less-risky way to grow rich in the stock market. Litman says you don't need dozens of investments, overpriced advisers, or hedge funds. You just need these 3 stocks, which have helped Litman's own mom earn 3,400%.
Apple Has the Potential To Crush Meta's Ray-Ban Smart Glasses, Says Ming-Chi Kuo, But The Tech Giant Has Been 'Surprisingly Slow'
Analyst Ming-Chi Kuo believes Apple has the potential to surpass Meta's Ray-Ban smart glasses, but notes the company's slow progress in this market could delay its dominance.
650% Later, Rocket Lab CEO Isn't One Bit Worried
Rocket Lab CEO Peter Beck highlights strong demand for launches from both commercial and government customers.
From Ferrari to Bombardier - This Tiny Company Is Everywhere - Ad
A $150M disruptor is transforming glass into real-time displays and vision systems. Already embedded in global OEMs and Tier 1s, it's scaling fast - yet still under Wall Street's radar.
BigBear.Ai, Nike, Core Scientific, Cyngn, And Amazon: Why These 5 Stocks Are On Investors' Radars Today
The S&P 500 index soared to record highs on Thursday, marking a significant recovery from the steep selloff experienced just a few months ago.
Cramer Praises Monster Beverage As 'Smoking Hot,' Warns Investors About This AI Stock
Cramer recommends buying Okta (OKTA) as it reported strong earnings, but not to trust Nebius Group (NBIS), while Sweetgreen (SG) and Monster Beverage (MNST) have mixed views. He also suggests buying McDonald's (MCD) while their partnership with Krispy Kreme (DNUT) will end in 2025.
Copper's Spiking - And This Junior Has the Grades to Match - Ad
Copper is climbing again - and this time, it looks tariff-proof. A $31M junior just posted nearly 1B lbs of copper equivalent. With insiders and institutions piling in, this could be the next breakout.
House Republicans race toward a final vote on Trump's tax bill, daring critics to oppose
WASHINGTON (AP) — Republican leaders in the House are sprinting toward a Wednesday vote on President Donald Trump's , determined to seize momentum from a in the Senate while essentially daring members to defy their party's leader and vote against it.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.